CD34 and immunodeficiency disease: De Ravin et al. (22) used CRISPR-Cas9 to repair a mutation in the CYBB gene of CD34+ hematopoietic stem and progenitor cells (HSPCs) from patients with the immunodeficiency disorder X-CGD.